Search

everythinglearnresearchcommunity

for

Search:↓

Blocking a specific enzyme in male rat fetuses leads to the development of nipples and feminized genitalia.

Women also use 5α-reductase inhibitors, and their effects differ from men.

5α-reductase inhibitors effectively treat enlarged prostate and hair loss but require careful use due to possible side effects.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Some patients may experience lasting sexual dysfunction, depression, and other side effects from 5α-reductase inhibitor therapy.

Taking 5-alpha reductase inhibitors might be linked to breast cancer in men.

5-Alpha reductase inhibitors help treat enlarged prostate but may cause sexual side effects.

The research identified and described a gene important for hormone conversion in endangered catfish, which varies in activity during different reproductive stages and after hormone treatment.

Plant-based compounds may offer safer prostate cancer treatment with fewer side effects.

Finasteride's molecular properties and active sites were identified using computational methods.

Finasteride poorly inhibits type 1 5AR, affecting its effectiveness.

Neuroactive steroids and the enzyme 5α-reductase might be involved in the development of Tourette's syndrome.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

New compounds may help treat prostate issues without affecting androgen receptors.

Certain progesterone derivatives can inhibit enzymes and reduce androgenic activity, potentially affecting prostate growth.

5α-reductase inhibitors can interfere with doping tests by masking banned substances.

5-alpha reductase inhibitors may cause sexual side effects, breast complications, and other health risks in men with hair loss.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

5α reductase inhibitors treat hair loss but may cause sexual side effects and risks.

2-Hydroxy-1,4-naphthoquinone is a strong 5α-reductase inhibitor.

The new compounds may be more effective and cheaper than current treatments for conditions like baldness.

Higher enzyme levels found in women with hair loss, suggesting hormone imbalance.

5α-reductase-2 deficiency causes ambiguous genitalia at birth and affects male sexual development, but individuals often develop male characteristics at puberty.

Treatment with 5α-reductase inhibitors is linked to a delay in prostate cancer diagnosis and may affect survival rates.

Researchers found new potential but less potent rat enzyme inhibitors using a 3D model.

5α-reductase inhibitors help shrink the prostate, improve urinary symptoms, and may reduce prostate cancer risk.

5-alpha reductase inhibitors help with benign prostatic hyperplasia but don't cure it, and more research is needed.

Genetic variations may affect how well finasteride works for BPH patients.

5α-reductase inhibitors do not increase anaemia risk compared to α-blockers in men with BPH.